Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX19.390,04+0,87 %

Gold2.656,990,00 %

Öl (Brent)79,04-0,57 %

Dow Jones42.865,63+0,97 %

US Tech 10020.269,38+0,14 %

EUR/USD1,09379+0,02 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

Enfusion Registered (A) Aktie

Aktie

ISIN: US2928121043 WKN: A3C602 SYM: ENFN Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

8,9900

USD

+0,45 %

+0,0400 USD

Letzter Kurs 02:04:01 NYSE

Geldkurs

11.10.24

8,9800

USD

6.000 STK

Briefkurs

11.10.24

8,9900

USD

9.400 STK

Enfusion Registered (A) Aktie kaufen

Neueste Nachrichten

Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation 10.10.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion Announces Date of Third Quarter 2024 Results 03.10.24 · Business Wire (engl.) · Enfusion Registered (A)
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm 04.09.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings 22.08.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings 14.08.24 · Business Wire (engl.) · Enfusion Registered (A)
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm 10.08.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion Announces Second Quarter 2024 Results 06.08.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility 02.08.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion Announces Date of Second Quarter 2024 Results 16.07.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion To Present at Upcoming Investor Events 29.05.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion Announces First Quarter 2024 Results 09.05.24 · Business Wire (engl.) · Enfusion Registered (A)
Enfusion Announces Date of First Quarter 2024 Results 18.04.24 · Business Wire (engl.) · Enfusion Registered (A)

1
2

Meistgelesen

7 Tage
30 Tage
12 Monate

Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation 108 Leser

Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation 108 Leser
Enfusion Announces Date of Third Quarter 2024 Results 104 Leser

Enfusion to Host Investor Day on March 19, 2024 164 Leser
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the ... 156 Leser
Enfusion Announces Appointment of Chief Operating Officer 148 Leser
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged ... 128 Leser
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion 124 Leser
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the ... 112 Leser
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation 108 Leser
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged ... 108 Leser
Enfusion Announces Date of Third Quarter 2024 Results 104 Leser
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results 104 Leser